STOCK TITAN

Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Inotiv (NASDAQ: NOTV), a contract research organization focused on nonclinical and analytical drug discovery and development services, has announced its participation in the upcoming Jefferies Global Healthcare Conference in New York. Robert Leasure Jr., President and CEO, will deliver a presentation on June 4 at 3:45 p.m. ET. The presentation will be available via live webcast through the company's investor relations website section and will remain accessible for approximately 90 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – NOTV

+0.47%
1 alert
+0.47% News Effect

On the day this news was published, NOTV gained 0.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer will present at the upcoming Jefferies Global Healthcare Conference in New York. The live presentation will take place on Wednesday, June 4 at 3:45 p.m. ET.

The live webcast can be accessed in the “Investors” section of Inotiv’s website and will be archived for approximately 90 days following the event.

About the Company

Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs and medical devices to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical research and development projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotiv.com/.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to comply with covenants under its credit agreement, compliance with the Resolution and Plea Agreements with the DOJ and the expected impacts on the Company related to the compliance plan, compliance monitor, and the expected financial commitments, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.

Company ContactInvestor Relations
Inotiv, Inc.LifeSci Advisors
Beth A. Taylor, Chief Financial OfficerSteve Halper
(765) 497-8381(646) 876-6455
beth.taylor@inotiv.comshalper@lifesciadvisors.com

FAQ

When is Inotiv (NOTV) presenting at the Jefferies Global Healthcare Conference 2025?

Inotiv's CEO Robert Leasure Jr. will present on Wednesday, June 4, 2025, at 3:45 p.m. ET at the Jefferies Global Healthcare Conference in New York.

How can I watch Inotiv's (NOTV) presentation at the Jefferies Healthcare Conference?

The presentation can be accessed via live webcast through the 'Investors' section of Inotiv's website and will be archived for approximately 90 days following the event.

Who is presenting for Inotiv (NOTV) at the Jefferies Global Healthcare Conference 2025?

Robert Leasure Jr., President and Chief Executive Officer of Inotiv, will be presenting at the conference.

What services does Inotiv (NOTV) provide as a company?

Inotiv is a contract research organization that specializes in nonclinical and analytical drug discovery and development services, as well as research models and related products and services.
Inotiv Inc

NASDAQ:NOTV

NOTV Rankings

NOTV Latest News

NOTV Latest SEC Filings

NOTV Stock Data

9.12M
31.05M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
WEST LAFAYETTE